309. 進行性ミオクローヌスてんかん Progressive myoclonus epilepsy Clinical trials / Disease details

臨床試験数 : 11 / 薬物数 : 15 - (DrugBank : 2) / 標的遺伝子数 : 4 - 標的パスウェイ数 : 9

diseases per page:

Showing 1 to 10 of 11 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03351569 (ClinicalTrials.gov)	December 9, 2015	27/10/2017	Intravenous Immunoglobulin for Unverricht-Lundborg Disease.	Intravenous Immunoglobulin for Unverricht-Lundborg Disease: Single-patient Trial.	Unverricht-Lundborg Disease	Drug: Intravenous immunoglobulin	Azienda Socio Sanitaria Territoriale di Mantova	NULL	Active, not recruiting	18 Years	25 Years	Male	1	Phase 3	NULL
2	EUCTR2007-003210-33-FI (EUCTR)	03/08/2007	13/06/2007	Effect of ropinirole hydrochloride in progressive myoclonic epilepsy of Unverricht–Lundborg type	Effect of ropinirole hydrochloride in progressive myoclonic epilepsy of Unverricht–Lundborg type	Progressive myoclonus epilepsyof the Unverricht–Lundborg disease (ULD) type MedDRA version: 9.1;Leve ...	Trade Name: Requip Product Name: Ropinirole hydrochloride Other descriptive name: ROPINIROLE HYDROCHLORI ...	Department of Neurology, Turku University Hospital	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	15		Finland
3	EUCTR2006-000169-12-IT (EUCTR)	26/01/2007	10/01/2007	A multicenter, randomized, double-blind, placebo-controlled, parallel study to evaluate the efficacy ...	A multicenter, randomized, double-blind, placebo-controlled, parallel study to evaluate the efficacy ...	Unverricht-Lundborg Disease MedDRA version: 6.1;Level: PT;Classification code 10054895	Product Name: BRIVARACETAM Product Name: BRIVARACETAM	UCB S.A. Casa Madre	NULL	Not Recruiting			Female: yes Male: yes	42		Finland;Netherlands;France;Italy;Sweden
4	EUCTR2006-000169-12-NL (EUCTR)	27/12/2006	28/09/2006	A multicenter, randomized, double-blind, placebo-controlled, parallel study to evaluate the efficacy ...	A multicenter, randomized, double-blind, placebo-controlled, parallel study to evaluate the efficacy ...	Patients with genetically ascertained Unverricht-Lundborg disease(ULD). MedDRA version: 8.1;Level: L ...	Product Name: Brivaracetam Product Code: ucb 34714 INN or Proposed INN: brivaracetam Other descriptive ...	UCB S.A.	NULL	Not Recruiting			Female: yes Male: yes	42		Finland;Netherlands;France;Italy;Sweden
5	EUCTR2006-001536-46-FI (EUCTR)	21/11/2006	10/10/2006	A multicenter, randomized, double-blind, placebo-controlled, parallel study to evaluate the efficacy ...	A multicenter, randomized, double-blind, placebo-controlled, parallel study to evaluate the efficacy ...	Patients with genetically ascertained Unverricht-Lundborg disease(ULD). MedDRA version: 8.1;Level: L ...	Product Name: Brivaracetam Product Code: ucb 34714 Other descriptive name: (2S)-2-[(4R)-2-oxo-4-propyl ...	UCB S.A.	NULL	Not Recruiting			Female: yes Male: yes	42	Phase 3	France;Finland
6	EUCTR2006-001536-46-FR (EUCTR)	14/11/2006	25/08/2006	A multicenter, randomized, double-blind, placebo-controlled, parallel study to evaluate the efficacy ...	A multicenter, randomized, double-blind, placebo-controlled, parallel study to evaluate the efficacy ...	Patients with genetically ascertained Unverricht-Lundborg disease(ULD). MedDRA version: 8.1;Level: L ...	Product Name: Brivaracetam Product Code: ucb 34714 Other descriptive name: (2S)-2-[(4R)-2-oxo-4-propyl ...	UCB S.A.	NULL	Not Recruiting			Female: yes Male: yes	42	Phase 3	France;Finland
7	EUCTR2006-000169-12-FR (EUCTR)	03/11/2006	25/08/2006	A multicenter, randomized, double-blind, placebo-controlled, parallel study to evaluate the efficacy ...	A multicenter, randomized, double-blind, placebo-controlled, parallel study to evaluate the efficacy ...	Patients with genetically ascertained Unverricht-Lundborg disease(ULD). MedDRA version: 8.1;Level: L ...	Product Name: Brivaracetam Product Code: ucb 34714 INN or Proposed INN: brivaracetam Other descriptive ...	UCB S.A.	NULL	Not Recruiting			Female: yes Male: yes	42	Phase 3	France;Finland;Netherlands;Italy;Sweden
8	NCT00357669 (ClinicalTrials.gov)	November 2006	25/7/2006	Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease in Adolescents and Adults	A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Study to Evaluate the Efficac ...	Unverricht-Lundborg Disease	Drug: Brivaracetam 25 mg;Drug: Brivaracetam 50 mg;Other: Placebo	UCB Pharma SA	NULL	Completed	16 Years	N/A	Both	50	Phase 3	Finland;France;Italy;Netherlands;Réunion;Sweden;Tunisia
9	NCT00368251 (ClinicalTrials.gov)	November 2006	23/8/2006	Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease (ULD) in Adolescents and Adults	A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Study to Evaluate the Efficacy ...	Unverricht-Lundborg Disease	Other: Placebo;Drug: BRV 2.5 mg;Drug: BRV 25 mg;Drug: BRV 50 mg	UCB Pharma	NULL	Completed	16 Years	N/A	All	56	Phase 3	United States;Canada;Finland;France;Israel;Russian Federation;Serbia;Tunisia;Former Serbia and Monte ...
10	EUCTR2006-000169-12-SE (EUCTR)	06/10/2006	07/08/2006	A multicenter, randomized, double-blind, placebo-controlled, parallel study to evaluate the efficacy ...	A multicenter, randomized, double-blind, placebo-controlled, parallel study to evaluate the efficacy ...	Patients with genetically ascertained Unverricht-Lundborg disease(ULD). MedDRA version: 8.1;Level: L ...	Product Name: Brivaracetam Product Code: ucb 34714 INN or Proposed INN: brivaracetam Other descriptive ...	UCB Pharma S.A.	NULL	Not Recruiting			Female: yes Male: yes	45		Finland;Netherlands;France;Italy;Sweden

First Previous1 2Next Last